Compound News and Research

RSS

Biocryst Wins Potentially $22M NIAID Contract To Develop Marburg Virus Disease Drug

...

17 Sep 2013

NIEHS grant renewal opens next chapter in 18-year research effort into brain injury biomarker

The National Institute of Environmental Health Sciences (NIEHS) has awarded a five-year, $1.5 million grant extension to Columbia University's Mailman School of Public Health to fund research into the function of a biomarker for brain injury called Translocator Protein 18 kDa, better known as TSPO, in order to better understand its function in brain injury and inflammation and discover targets for therapy.

17 Sep 2013

Kinder chemistry promises cleaner and safer pharmaceuticals with fewer side-effects

A new and kinder chemistry promises cleaner and subsequently safer pharmaceuticals with fewer side-effects. The ground-breaking method, developed by a chemistry research group at the University of Copenhagen, is now published in the internationally renowned journal, Chemical Communications, as "Site-selective three component reaction for dual functionalization of peptides".

16 Sep 2013

Research findings bring scientists one step closer to preventing HIV infections

In a long-awaited finding, a team of Chinese and US scientists has determined the high-resolution atomic structure of a cell-surface receptor that most strains of HIV use to get into human immune cells. The researchers also showed where maraviroc, an HIV drug, attaches to cells and blocks HIV’s entry.

13 Sep 2013

CardioExcyte 96 for cardiac toxicity profiling and screening introduced by Nanion

Cardiac safety assessment is a vital part of drug development since late withdrawals of compound candidates, due to heart liability issues such as ventricular arrhythmia, are very costly. In-vivo methods give highly relevant information but are extremely low throughput allowing the analysis of only a handful of compounds.

From Nanion Technologies 13 Sep 2013

Scottsdale Healthcare, TGen initiate Thunder God vine clinical trial in pancreatic cancer patients

Taking a page from Chinese herbal medicine, Scottsdale Healthcare and the Translational Genomics Research Institute today initiated the first-in-human clinical trial for pancreatic cancer patients using a compound derived from a plant known as "Thunder God vine."

13 Sep 2013

Microbiologist finds breakthrough herbal medicine treatment for common human fungal pathogen

A Kansas State University microbiologist has found a breakthrough herbal medicine treatment for a common human fungal pathogen that lives in almost 80 percent of people.

13 Sep 2013

Omeros announces positive data from OMS824 Phase 1 clinical trial

Omeros Corporation today announced positive data from the Company's Phase 1 clinical trial evaluating the pharmacokinetics of OMS824, the lead compound in Omeros' phosphodiesterase 10 program, further supporting that OMS824 can achieve superior target engagement with lesser side effects compared to other PDE10 inhibitors in development.

12 Sep 2013

BioTek's new MultiFlo FX Microplate Dispenser combines dispensing and washing in one platform

BioTek's new MultiFlo FX Microplate Dispenser offers up to four independent reagent dispensers and a washer in one compact and modular platform to simplify and automate microplate-based liquid handling processes, thus saving time and reducing reagent costs.

12 Sep 2013

Hydroxyurea treatment prevents complications, lowers medical care costs in children sickle cell disease

The benefits of hydroxyurea treatment in people with sickle cell disease are well known -- fewer painful episodes, fewer blood transfusions and fewer hospitalizations. Now new research from the Johns Hopkins Children's Center and other institutions reveals that by preventing such complications, the drug can also considerably lower the overall cost of medical care in children with this condition.

12 Sep 2013

Astrazeneca Licenses Merck's Cancer Candidate MK-1775

...

11 Sep 2013

Biogen Idec, Amicus Launch Parkinson's Collaboration

...

10 Sep 2013

Bayer, Broad On Five-Year Mission To Search For Novel Cancer Therapeutics

...

10 Sep 2013

Chemists Find New Way To Put The Brakes On Cancer

...

10 Sep 2013

Banook Central Imaging, Oncodesign partner to expand use of new approaches in pharmaco-imaging

Oncodesign, a contract research laboratory dedicated to the discovery of new anticancer therapies, and Banook Central Imaging, a company specializing in the centralized reading of medical images, today announce the start of a partnership to expand the use of new approaches in pharmaco-imaging.

10 Sep 2013

Study suggests that omega-3 fish oil might help protect against alcohol-related dementia

A Loyola University Chicago Stritch School of Medicine study suggests that omega-3 fish oil might help protect against alcohol-related dementia.

10 Sep 2013

Oncodesign, Banook Central Imaging To Develop Cancer Biomarkers

...

9 Sep 2013

Medivir discontinues development of hepatitis B compound MIV-210 on collaboration with Daewoong

Medivir AB today announced that it has discontinued the development of its hepatitis B compound MIV-210 based on a joint decision with Daewoong Pharmaceutical Co. Ltd.,.

7 Sep 2013

Viamet initiates phase 2 clinical trial of antifungal agent VT-1161 for treatment of vulvovaginal candidiasis

Viamet Pharmaceuticals, Inc. announced today the initiation of the phase 2 clinical program for its antifungal agent VT-1161. The initial phase 2 study is designed to evaluate the safety and efficacy of VT-1161 in the treatment of vulvovaginal candidiasis (VVC) and is being conducted at leading clinical centers in the United States.

7 Sep 2013

Medivir, Daewoong Discontinue HBV Drug Development

...

6 Sep 2013

Compound News and Research

Biocryst Wins Potentially $22M NIAID Contract To Develop Marburg Virus Disease Drug

NIEHS grant renewal opens next chapter in 18-year research effort into brain injury biomarker

Kinder chemistry promises cleaner and safer pharmaceuticals with fewer side-effects

Research findings bring scientists one step closer to preventing HIV infections

CardioExcyte 96 for cardiac toxicity profiling and screening introduced by Nanion

Scottsdale Healthcare, TGen initiate Thunder God vine clinical trial in pancreatic cancer patients

Microbiologist finds breakthrough herbal medicine treatment for common human fungal pathogen

Omeros announces positive data from OMS824 Phase 1 clinical trial

BioTek's new MultiFlo FX Microplate Dispenser combines dispensing and washing in one platform

Hydroxyurea treatment prevents complications, lowers medical care costs in children sickle cell disease

Astrazeneca Licenses Merck's Cancer Candidate MK-1775

Biogen Idec, Amicus Launch Parkinson's Collaboration

Bayer, Broad On Five-Year Mission To Search For Novel Cancer Therapeutics

Chemists Find New Way To Put The Brakes On Cancer

Banook Central Imaging, Oncodesign partner to expand use of new approaches in pharmaco-imaging

Study suggests that omega-3 fish oil might help protect against alcohol-related dementia

Oncodesign, Banook Central Imaging To Develop Cancer Biomarkers

Medivir discontinues development of hepatitis B compound MIV-210 on collaboration with Daewoong

Viamet initiates phase 2 clinical trial of antifungal agent VT-1161 for treatment of vulvovaginal candidiasis

Medivir, Daewoong Discontinue HBV Drug Development

Enhancing confidence in chemical ionization spectrometry data eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News